Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Exploratory Analyses from the Phase Three INDIGO Study Suggest Potential Mechanism of Seizure Control Through Tumor Volume Reduction Under Treatment With Vorasidenib

Author:Peters, Katherine   Mellinghoff, Ingo   Wick, Wolfgang   Van Den Bent, Martin   Blumenthal, Deborah   Touat, Mehdi   Clarke, Jennifer   Mendez, Joe   Welsh, Liam   Mason, Warren   Hottinger, Andreas   Sepulveda, Juan   Soffietti, Riccardo   Zhao, Dan   Yi, Denise   Weidl, Daniel   Steelman, Lori   Hassan, Islam   Wen, Patrick   Cloughesy, Timothy   

Session Name:S28: Neuro-oncology: Clinical and Practice Updates  

Topic:Neuro-oncology  

Program Number:S28.002  

Author Institution:Duke University Medical Center, Durham, NC  Memorial Sloan Kettering Cancer Center, New York, NY  Universitätsklinikum Heidelberg, Heidelberg & German Cancer Research Center, Heidelberg, Germany  Erasmus Medical Center, Rotterdam, Netherlands  Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel  Pitié Salpêtrière Hospital, Assistance Publique – Hôpitaux de Paris (AP-HP) Sorbonne Université, Paris, France  UCSF, San Francisco, CA  Huntsman Cancer, Salt Lake City, UT  The Royal Marsden Hospital, London, United Kingdom  Toronto General Hospital, Toronto, ON, Canada  University Hospital of Lausanne, Lausanne, Switzerland  Hospital Universitario 12 de Octubre, Madrid, Spain  University of Turin, Torino, Italy  Servier Pharmaceuticals, CAMBRIDGE, MA  Servier Pharmaceuticals, Boston, MA  Servier Deutschland GmbH, Munich, Germany  Servier Pharmaceuticals, Wilmington, MA  Dana-Farber/Brigham and Women'S Cancer Center, Boston, MA  University of California Los Angeles, Los Angeles, CA  

Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding: Final Analyses of the Prospective, Multicenter, Open-label, Phase IV Studies MINORE and SOPRANINO

Author:Dobson, Ruth   Bove, Riley   Hellwig, Kerstin   Oreja-Guevara, Celia   Derfuss, Tobias J.   Shah, Anna   Graham, Edith L.   McElrath, Thomas F.   Pietrasanta, Carlo   Maillart, Elisabeth   Jacobs, Dina   Kazlauskaite, Agne   Alves, Daniela   Raposo, Catarina   Craveiro, Licinio   Lin, Chien-Ju   Pasquarelli, Noemi   Vukusic, Sandra   

Session Name:S40: Multiple Sclerosis: Clinical Trials/Science and Real-world Evidence  

Topic:Multiple Sclerosis  

Program Number:S40.002  

Author Institution:Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK, London, United Kingdom  Department of Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA, Berkeley, CA  Katholisches Klinikum Bochum, St. Josef Hospital, Universitätsklinikum, Bochum, Germany, Bochum, Germany  Neurology, Hospital Clínico San Carlos, IdISSC, Madrid, Spain, Madrid, Spain  University Hospital Basel, University of Basel, Basel, Switzerland, Basel, Switzerland  Rocky Mountain MS Center, Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA, Aurora, CO  Multiple Sclerosis and Neuroimmunology, Northwestern University, Chicago, IL, USA, Chicago, IL  Division of Maternal-Fetal Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, Boston, MA  NICU, Department of Woman, Child and Newborn, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico and Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, Milan, Italy  Neurology Department, Hôpital de la Pitié Salpêtrière, Assistance Publique des Hôpitaux de Paris, Paris, France, Paris, France  Department of Neurology, Perelman School of Medicine at the Hospital of the University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA  F. Hoffmann-La Roche Ltd, Basel, Switzerland, Basel, Switzerland  Roche Products Ltd, Welwyn Garden City, UK, Welwyn Garden City, United Kingdom  Service de Neurologie et Sclérose en Plaques, Fondation Eugène Devic EDMUS contre la Sclérose en Plaques, Hôpital Neurologique Pierre Wertheimer, Lyon, France, BRON Cedex, France